NewsRx

Search our medical news database

Drug Discovery

FLIPR Calcium 3 Assay Kit launched

Published in Biotech Business Week, February 24th, 2003

Molecular Devices Corp. (MDCC), a leader in innovative solutions for drug discovery and life-sciences research, announced the launch of the FLIPR Calcium 3 Assay Kit.

This kit, using technology licensed exclusively to Molecular Devices by Bayer, AG, addresses a broad spectrum of drug targets in high-throughput screening, including those that have proved problematic with other calcium assay formats.

Cell-based calcium flux assays are considered one of the most important screening techniques used in pharmaceutical drug discovery, and all of the major pharmaceutical companies utilize Molecular Devices' FLIPR system for these assays. However, many drug...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook